Astellas Pharma Inc. announced that DIGITIVA, a non-invasive digital health solution for heart failure management, has been listed with the US Food and Drug Administration (FDA). DIGITIVA is ...
GS1 India, a supply chain standards organization set up under the ministry of commerce, Government of India, hosted the ...
BD expands capacity for advanced prefillable syringes and enhances injection experience for next generation of biologics: Le ...
Experts urge immediate action against the growing health crisis on World Alzheimer’s Day: Our Bureau, Mumbai Friday, September 20, 2024, 16:45 Hrs [IST] On the occasion of World ...
Laurentis inks MoU with Colibri Isotopes to carry out isotopes irradiation services: Clarington Friday, September 20, 2024, 17:00 Hrs [IST] Laurentis Energy Partners (Laurentis) a ...
EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...
Bone marrow cancer drug shows success in treatment of rare blood disorder: Study: Bethesda, Maryland Friday, September 20, 2024, 16:00 Hrs [IST] A clinical trial supported by the ...
Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...
SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome: Tel Aviv, Israel Friday, September 20, 2024, 17:30 Hrs [IST] SciSparc Ltd., a specialty clini ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback